Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)

SHA:688506 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,220	403.96	1,005	154.22	47.2
Trading Asset Securities	-	-	-	-	197.54
Cash & Short-Term Investments	3,220	403.96	1,005	154.22	244.74
Cash Growth	697.13%	-59.79%	551.49%	-36.99%	-0.83%
Accounts Receivable	138.71	137.85	267.92	134.95	226.49
Other Receivables	34.33	3.9	5.14	2.95	0.64
Receivables	173.05	141.75	273.06	137.9	227.13
Inventory	162.19	140.91	101.33	82.33	65.77
Other Current Assets	2,752	89.2	47.22	49.36	33.21
Total Current Assets	6,307	775.82	1,426	423.81	570.85
Property, Plant & Equipment	573.09	534.79	420.26	404.98	380.91
Other Intangible Assets	26.68	28	29.53	31.16	32.88
Long-Term Deferred Tax Assets	179.2	76.18	83.23	65.8	48.2
Long-Term Deferred Charges	18.4	1.82	1.79	1.16	0.67
Other Long-Term Assets	32.79	8.5	30.28	24.54	8.47
Total Assets	7,137	1,425	1,991	951.46	1,042
Accounts Payable	498	160.17	128.85	45.96	67.96
Accrued Expenses	79.48	257.88	244.81	139.81	204.43
Short-Term Debt	595.5	275.12	155.13	161.23	150.21
Current Portion of Long-Term Debt	255.48	174.37	30.47	0.02	-
Current Portion of Leases	-	46.13	68.82	24.23	-
Current Income Taxes Payable	31.29	0.01	4.96	1.54	10.31
Current Unearned Revenue	356.13	8.67	17.42	10.78	18.1
Other Current Liabilities	164.06	131.48	86.74	87.75	81.44
Total Current Liabilities	1,980	1,054	737.2	471.32	532.45
Long-Term Debt	1,189	183.92	239.96	50	-
Long-Term Leases	28.13	8.65	52.95	51.42	-
Long-Term Unearned Revenue	42.27	15.63	13.29	31.04	37.24
Long-Term Deferred Tax Liabilities	1.94	-	0.08	-	0.08
Other Long-Term Liabilities	9.73	11.19	14.05	15.81	20.14
Total Liabilities	3,251	1,273	1,058	619.61	589.91
Common Stock	401	401	401	360.9	360.9
Additional Paid-In Capital	885.84	858.69	858.55	14.17	14.07
Retained Earnings	2,599	-1,109	-328.45	-45.98	74.01
Comprehensive Income & Other	0.53	1.13	2.79	2.76	3.1
Total Common Equity	3,886	151.87	933.89	331.85	452.08
Shareholders' Equity	3,886	151.87	933.89	331.85	452.08
Total Liabilities & Equity	7,137	1,425	1,991	951.46	1,042
Total Debt	2,069	688.19	547.33	286.91	150.21
Net Cash (Debt)	1,152	-284.23	457.41	-132.69	94.53
Net Cash Growth	-	-	-	-	82.72%
Net Cash Per Share	2.87	-0.71	1.26	-0.37	0.27
Filing Date Shares Outstanding	400.47	401	401	360.9	344.56
Total Common Shares Outstanding	400.47	401	401	360.9	344.56
Working Capital	4,327	-278.01	689.14	-47.51	38.4
Book Value Per Share	9.70	0.38	2.33	0.92	1.31
Tangible Book Value	3,859	123.88	904.36	300.69	419.2
Tangible Book Value Per Share	9.64	0.31	2.26	0.83	1.22
Buildings	-	304.56	302.23	300.82	252.7
Machinery	-	554.25	439.83	419.75	363.73
Construction In Progress	-	81.37	67.21	18.18	76.71

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.